Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2024 - 2026)

Lucid Diagnostics filings provide 2 years of Other Non-Current Liabilities readings, the most recent being $24.0 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 29.03% to $24.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.0 million, a 29.03% increase, with the full-year FY2025 number at $24.0 million, up 29.03% from a year prior.
  • Other Non-Current Liabilities hit $24.0 million in Q4 2025 for Lucid Diagnostics, up from $18.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $24.0 million in Q4 2025 to a low of $18.6 million in Q4 2024.